Review
Copyright ©The Author(s) 2017.
World J Hepatol. May 18, 2017; 9(14): 645-656
Published online May 18, 2017. doi: 10.4254/wjh.v9.i14.645
Table 3 Summary of dose constraints by number of fractions
Organ at risk3 fraction (RAS trial[102])5 fraction (RTOG 1112[103])QUANTEC (1.8-2 Gy per fraction)[104]Toxicity
Liver excluding CTV700 mL < 15 GyV 10 < 70%D mean < 30 GyRadiation induced liver dysfunction
EsophagusD 1 mL < 21 GyD 0.5 mL < 32 GyV 35 < 50%Esophagitis
StomachD 1 mL < 21 GyD 0.5 mL < 30 GyD 100 < 35 GyUlceration
KidneyD 35% < 15 GyD mean < 10 GyD mean < 28 Gy (1.8-2 Gy per fraction)Renal dysfunction
Bowel and duodenumD 1 mL < 21 GyD 0.5 mL < 30 GyD 45 < 195 ccEnteritis/fistula
Spinal cordDmax < 18 GyD 0.5 mL < 25 GyDmax = 45Myelopathy
HeartD 1 mL, 30 GyD 30 mL < 30 GyV 25 < 10%Pericarditis